Orthopediatrics (KIDS) EPS (Diluted) Growth (1y) (2020 - 2026)
Orthopediatrics (KIDS) EPS (Diluted) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | -18.71% |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | 13.88% |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | 98.71% |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | 95.96% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | -29.80% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | 114.19% |
| 10 | Orthopediatrics | 462.69 Mn | 448.44 Mn | 43.39 Mn | 1.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66% |
| Dec 31, 2025 | 38.15% |
| Sep 30, 2025 | -46.18% |
| Jun 30, 2025 | -16.40% |
| Mar 31, 2025 | -34.16% |
| Dec 31, 2024 | -135.97% |
| Sep 30, 2024 | -69.45% |
| Jun 30, 2024 | -104.93% |
| Mar 31, 2024 | -13.10% |
| Dec 31, 2023 | 21.24% |
| Sep 30, 2023 | -123.17% |
| Jun 30, 2023 | -655.50% |
| Mar 31, 2023 | 35.64% |
| Dec 31, 2022 | -10,126.10% |
| Sep 30, 2022 | 864.43% |
| Jun 30, 2022 | 91.37% |
| Mar 31, 2022 | 13.08% |
| Dec 31, 2021 | 100.48% |
| Sep 30, 2021 | 52.05% |
| Jun 30, 2021 | 63.80% |